Propanc Biopharma Inc. logo

Propanc Biopharma Inc. (PPCB)

Market Open
15 Jun, 17:03
NASDAQ NASDAQ
$
2. 09
-0.18
-8.1013%
$
2.12M Market Cap
0 P/E Ratio
- Div Yield
608,234 Volume
0 Eps
$ 2.27
Previous Close
Investors:
Add Transaction
Day Range
1.92 2.39
Year Range
1.3 270.25
Want to track PPCB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Propanc Biopharma Inc. (PPCB) Statistics

Valuation metrics

Market Cap 2.12M
Enterprise value 3.11M
Trailing P/E (ttm) -0.11
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.21
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.18

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 628.01K
Average volume (90 days) 171.78K

Price summary

52-Week low 1.3
52-Week high 270.25
Beta -
50-Day moving average 2.16
200-Day moving average 7.23

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 18 May 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.28%
Return on equity -1.51%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -20.47
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.49
Total debt (mrq) -
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 2.37%
Book value per share (mrq) 10.96

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -